These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 31980113)

  • 21. The Impact of Technology on Current Diabetes Management.
    Garvey K; Wolfsdorf JI
    Pediatr Clin North Am; 2015 Aug; 62(4):873-88. PubMed ID: 26210622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of artificial pancreas in the non-adult population: A systematic review and network meta-analysis.
    Karageorgiou V; Papaioannou TG; Bellos I; Alexandraki K; Tentolouris N; Stefanadis C; Chrousos GP; Tousoulis D
    Metabolism; 2019 Jan; 90():20-30. PubMed ID: 30321535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modern diabetes devices in the school setting: Perspectives from school nurses.
    March CA; Nanni M; Kazmerski TM; Siminerio LM; Miller E; Libman IM
    Pediatr Diabetes; 2020 Aug; 21(5):832-840. PubMed ID: 32249474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biopsychosocial Factors Associated With Satisfaction and Sustained Use of Artificial Pancreas Technology and Its Components: a Call to the Technology Field.
    Forlenza GP; Messer LH; Berget C; Wadwa RP; Driscoll KA
    Curr Diab Rep; 2018 Sep; 18(11):114. PubMed ID: 30259309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parental attitudes towards overnight closed-loop glucose control in children with type 1 diabetes.
    Elleri D; Acerini CL; Allen JM; Hayes J; Pesterfield C; Wilinska ME; Dunger DB; Hovorka R
    Diabetes Technol Ther; 2010 Jan; 12(1):35-9. PubMed ID: 20082583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Automated Insulin Delivery in Adults.
    Boughton CK; Hovorka R
    Endocrinol Metab Clin North Am; 2020 Mar; 49(1):167-178. PubMed ID: 31980116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing patient-reported outcomes for automated insulin delivery systems: the psychometric properties of the INSPIRE measures.
    Weissberg-Benchell J; Shapiro JB; Hood K; Laffel LM; Naranjo D; Miller K; Barnard K
    Diabet Med; 2019 May; 36(5):644-652. PubMed ID: 30761592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. One-year experience of hybrid closed-loop system in children and adolescents with type 1 diabetes previously treated with multiple daily injections: drivers to successful outcomes.
    Petrovski G; Al Khalaf F; Campbell J; Umer F; Almajaly D; Hamdan M; Hussain K
    Acta Diabetol; 2021 Feb; 58(2):207-213. PubMed ID: 33044604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Youth Involvement in the Decision to Start CGM Predicts Subsequent CGM Use.
    Miller VA; Xiao R; Slick N; Feudtner C; Willi SM
    Diabetes Care; 2020 Oct; 43(10):2355-2361. PubMed ID: 32703764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Persistent heterogeneity in diabetes technology reimbursement for children with type 1 diabetes: The SWEET perspective.
    Sumnik Z; Szypowska A; Iotova V; Bratina N; Cherubini V; Forsander G; Jali S; Raposo JF; Stipančic G; Vazeou A; Veeze H; Lange K;
    Pediatr Diabetes; 2019 Jun; 20(4):434-443. PubMed ID: 30773756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Type 1 diabetes technology pathway: consensus statement for the use of technology in Type 1 diabetes.
    Choudhary P; Campbell F; Joule N; Kar P;
    Diabet Med; 2019 May; 36(5):531-538. PubMed ID: 30773681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using Cluster Analysis to Understand Clinician Readiness to Promote Continuous Glucose Monitoring Adoption.
    Tanenbaum ML; Adams RN; Lanning MS; Hanes SJ; Agustin BI; Naranjo D; Hood KK
    J Diabetes Sci Technol; 2018 Nov; 12(6):1108-1115. PubMed ID: 29991281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychosocial benefits of insulin pump therapy in children with diabetes type 1 and their families: The pumpkin multicenter randomized controlled trial.
    Mueller-Godeffroy E; Vonthein R; Ludwig-Seibold C; Heidtmann B; Boettcher C; Kramer M; Hessler N; Hilgard D; Lilienthal E; Ziegler A; Wagner VM;
    Pediatr Diabetes; 2018 Dec; 19(8):1471-1480. PubMed ID: 30302877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Benefits and Challenges of Diabetes Technology Use in Older Adults.
    Toschi E; Munshi MN
    Endocrinol Metab Clin North Am; 2020 Mar; 49(1):57-67. PubMed ID: 31980121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. From Wary Wearers to d-Embracers: Personas of Readiness to Use Diabetes Devices.
    Tanenbaum ML; Adams RN; Iturralde E; Hanes SJ; Barley RC; Naranjo D; Hood KK
    J Diabetes Sci Technol; 2018 Nov; 12(6):1101-1107. PubMed ID: 30132692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influences on Technology Use and Efficacy in Type 1 Diabetes.
    Franklin V
    J Diabetes Sci Technol; 2016 May; 10(3):647-55. PubMed ID: 27022096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Technological Revolution: The Integration of New Treatments to Manage Type 1 Diabetes.
    Galderisi A; Sherr JL
    Pediatr Ann; 2019 Aug; 48(8):e311-e318. PubMed ID: 31426099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An integrative review of the psychosocial facilitators and challenges of continuous subcutaneous insulin infusion therapy in type 1 diabetes.
    Payk M; Robinson T; Davis D; Atchan M
    J Adv Nurs; 2018 Mar; 74(3):528-538. PubMed ID: 28960449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Family Support and Its Association with Glycemic Control in Adolescents with Type 1 Diabetes Mellitus in Riyadh, Saudi Arabia.
    AlHaidar AM; AlShehri NA; AlHussaini MA
    J Diabetes Res; 2020; 2020():5151604. PubMed ID: 32280715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.